Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Characterization of a short isoform of the kidney protein podocin in human kidney

Authors: Linus A Völker, Eva-Maria Schurek, Markus M Rinschen, Judit Tax, Barbara A Schutte, Tobias Lamkemeyer, Denise Ungrue, Bernhard Schermer, Thomas Benzing, Martin Höhne

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Steroid resistant nephrotic syndrome is a severe hereditary disease often caused by mutations in the NPHS2 gene. This gene encodes the lipid binding protein podocin which localizes to the slit diaphragm of podocytes and is essential for the maintenance of an intact glomerular filtration barrier. Podocin is a hairpin-like membrane-associated protein that multimerizes to recruit lipids of the plasma membrane. Recent evidence suggested that podocin may exist in a canonical, well-studied large isoform and an ill-defined short isoform. Conclusive proof of the presence of this new podocin protein in the human system is still lacking.

Methods

We used database analyses to identify organisms for which an alternative splice variant has been annotated. Mass spectrometry was employed to prove the presence of the shorter isoform of podocin in human kidney lysates. Immunofluorescence, sucrose density gradient fractionation and PNGase-F assays were used to characterize this short isoform of human podocin.

Results

Mass spectrometry revealed the existence of the short isoform of human podocin on protein level. We cloned the coding sequence from a human kidney cDNA library and showed that the expressed short variant was retained in the endoplasmic reticulum while still associating with detergent-resistant membrane fractions in sucrose gradient density centrifugation. The protein is partially N-glycosylated which implies the presence of a transmembranous form of the short isoform.

Conclusions

A second isoform of human podocin is expressed in the kidney. This isoform lacks part of the PHB domain. It can be detected on protein level. Distinct subcellular localization suggests a physiological role for this isoform which may be different from the well-studied canonical variant. Possibly, the short isoform influences lipid and protein composition of the slit diaphragm complex by sequestration of lipid and protein interactors into the endoplasmic reticulum.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler M-C, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000, 24: 349-354. 10.1038/74166.CrossRefPubMed Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler M-C, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000, 24: 349-354. 10.1038/74166.CrossRefPubMed
2.
go back to reference Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001, 108: 1621-1629.CrossRefPubMedPubMedCentral Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001, 108: 1621-1629.CrossRefPubMedPubMedCentral
3.
go back to reference Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler M-C, Antignac C: Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice. Mol Cell Biol. 2004, 24: 550-560. 10.1128/MCB.24.2.550-560.2004.CrossRefPubMedPubMedCentral Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler M-C, Antignac C: Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice. Mol Cell Biol. 2004, 24: 550-560. 10.1128/MCB.24.2.550-560.2004.CrossRefPubMedPubMedCentral
4.
go back to reference Huber TB, Schermer B, Müller RU, Höhne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstädt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T: Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci USA. 2006, 103: 17079-17086. 10.1073/pnas.0607465103.CrossRefPubMedPubMedCentral Huber TB, Schermer B, Müller RU, Höhne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstädt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T: Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci USA. 2006, 103: 17079-17086. 10.1073/pnas.0607465103.CrossRefPubMedPubMedCentral
5.
go back to reference Schermer B, Benzing T: Lipid-Protein Interactions along the Slit Diaphragm of Podocytes. J Am Soc Nephrol. 2009, 20: 473-478. 10.1681/ASN.2008070694.CrossRefPubMed Schermer B, Benzing T: Lipid-Protein Interactions along the Slit Diaphragm of Podocytes. J Am Soc Nephrol. 2009, 20: 473-478. 10.1681/ASN.2008070694.CrossRefPubMed
6.
go back to reference Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S: In situ evaluation of podocin in normal and glomerular diseases. Kidney Int. 2003, 64: 2092-2099. 10.1046/j.1523-1755.2003.00303.x.CrossRefPubMed Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S: In situ evaluation of podocin in normal and glomerular diseases. Kidney Int. 2003, 64: 2092-2099. 10.1046/j.1523-1755.2003.00303.x.CrossRefPubMed
7.
go back to reference Relle M, Cash H, Brochhausen C, Strand D, Menke J, Galle PR, Schwarting A: New perspectives on the renal slit diaphragm protein podocin. Mod Pathol. 2011, 24: 1101-1110. 10.1038/modpathol.2011.58.CrossRefPubMedPubMedCentral Relle M, Cash H, Brochhausen C, Strand D, Menke J, Galle PR, Schwarting A: New perspectives on the renal slit diaphragm protein podocin. Mod Pathol. 2011, 24: 1101-1110. 10.1038/modpathol.2011.58.CrossRefPubMedPubMedCentral
8.
go back to reference Wang W, Malcolm BA: Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. Biotechniques. 1999, 26: 680-682.PubMed Wang W, Malcolm BA: Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. Biotechniques. 1999, 26: 680-682.PubMed
9.
go back to reference Yamamoto T: Isolation and Enrichment of Glomeruli Using Sieving Techniques. Renal and Urinary Proteomics: Methods and Protocols. Edited by: Thongboonkerd V. 2009, Weinheim: Wiley-VCH Verlag, 1-7. 1CrossRef Yamamoto T: Isolation and Enrichment of Glomeruli Using Sieving Techniques. Renal and Urinary Proteomics: Methods and Protocols. Edited by: Thongboonkerd V. 2009, Weinheim: Wiley-VCH Verlag, 1-7. 1CrossRef
10.
go back to reference Rappsilber J, Mann M, Ishihama Y: Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007, 2: 1896-1906. 10.1038/nprot.2007.261.CrossRefPubMed Rappsilber J, Mann M, Ishihama Y: Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007, 2: 1896-1906. 10.1038/nprot.2007.261.CrossRefPubMed
11.
go back to reference Rinschen MM, Yu M-J, Wang G, Boja ES, Hoffert JD, Pisitkun T, Knepper MA: Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor–dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci USA. 2010, 107: 3882-3887. 10.1073/pnas.0910646107.CrossRefPubMedPubMedCentral Rinschen MM, Yu M-J, Wang G, Boja ES, Hoffert JD, Pisitkun T, Knepper MA: Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor–dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci USA. 2010, 107: 3882-3887. 10.1073/pnas.0910646107.CrossRefPubMedPubMedCentral
12.
go back to reference Wang G, Wu WW, Pisitkun T, Hoffert JD, Knepper MA, Shen R-F: Automated quantification tool for high-throughput proteomics using stable isotope labeling and LC-MSn. Anal Chem. 2006, 78: 5752-5761. 10.1021/ac060611v.CrossRefPubMed Wang G, Wu WW, Pisitkun T, Hoffert JD, Knepper MA, Shen R-F: Automated quantification tool for high-throughput proteomics using stable isotope labeling and LC-MSn. Anal Chem. 2006, 78: 5752-5761. 10.1021/ac060611v.CrossRefPubMed
13.
go back to reference Cox J, Mann M: MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008, 26: 1367-1372. 10.1038/nbt.1511.CrossRefPubMed Cox J, Mann M: MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008, 26: 1367-1372. 10.1038/nbt.1511.CrossRefPubMed
14.
go back to reference Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T: Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet. 2003, 12: 3397-3405. 10.1093/hmg/ddg360.CrossRefPubMed Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T: Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet. 2003, 12: 3397-3405. 10.1093/hmg/ddg360.CrossRefPubMed
15.
go back to reference Roselli S, Moutkine I, Gribouval O, Benmerah A, Antignac C: Plasma Membrane Targeting of Podocin Through the Classical Exocytic Pathway: Effect of NPHS2 Mutations. Traffic. 2004, 5: 37-44. 10.1046/j.1600-0854.2003.00148.x.CrossRefPubMed Roselli S, Moutkine I, Gribouval O, Benmerah A, Antignac C: Plasma Membrane Targeting of Podocin Through the Classical Exocytic Pathway: Effect of NPHS2 Mutations. Traffic. 2004, 5: 37-44. 10.1046/j.1600-0854.2003.00148.x.CrossRefPubMed
16.
go back to reference Benzing T: Signaling at the Slit Diaphragm. J Am Soc Nephrol. 2004, 15: 1382-1391. 10.1097/01.ASN.0000130167.30769.55.CrossRefPubMed Benzing T: Signaling at the Slit Diaphragm. J Am Soc Nephrol. 2004, 15: 1382-1391. 10.1097/01.ASN.0000130167.30769.55.CrossRefPubMed
17.
go back to reference Kadurin I, Huber S, Gründer S: A single conserved proline residue determines the membrane topology of stomatin. Biochem J. 2009, 418: 587-594. 10.1042/BJ20081662.CrossRefPubMed Kadurin I, Huber S, Gründer S: A single conserved proline residue determines the membrane topology of stomatin. Biochem J. 2009, 418: 587-594. 10.1042/BJ20081662.CrossRefPubMed
Metadata
Title
Characterization of a short isoform of the kidney protein podocin in human kidney
Authors
Linus A Völker
Eva-Maria Schurek
Markus M Rinschen
Judit Tax
Barbara A Schutte
Tobias Lamkemeyer
Denise Ungrue
Bernhard Schermer
Thomas Benzing
Martin Höhne
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-102

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.